BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 13.3//EN BEGIN:VTIMEZONE TZID:GMT Standard Time BEGIN:STANDARD DTSTART:20231002T020000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=10 TZNAME:GMT Standard Time TZOFFSETFROM:+0100 TZOFFSETTO:+0000 END:STANDARD BEGIN:DAYLIGHT DTSTART:20230301T010000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=1;BYMINUTE=0;BYMONTH=3 TZNAME:GMT Daylight Time TZOFFSETFROM:+0000 TZOFFSETTO:+0100 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:Date: \;10th December 2019\nTime: 14:00 - 15:30\nSpeakers:& nbsp\;PSI/EFSPI SIG Quantitative Decision-Making members:\n\n\n\n\n Pie rre Colin (Sanofi)\n Juan Abellan (GSK)\n Gaë\;lle Saint-Hilary (Servier)\n\nQuantitative methods to support decision-making in clinical d rug development already exist\, but may be unknown or unused by pharmaceut ical companies. We performed a survey among pharmaceutical companies\, tar geting people with different profiles (statisticians\, non-statisticians a nd decision-makers) working at different stages of the clinical developmen t (study level\, development level or portfolio level). This survey allowe d us to analyze which quantitative methods are known\, which quantitative methods are used (or not)\, what benefit is expected from this kind of met hods\, and what are the needs for a larger use of quantitative methods to support decision-making. It permitted to understand the gaps and some of t he issues associated to the use of such methods in drug development. The w ebinars are intended to share the learnings from the survey and to promote different quantitative methods for decision-making.\nRegistration: \; To register for this free webinar\, please \;click here.\n\nPlease ema il \;PSI@mci-group.com \;if you have any questions. DTEND:20191210T153000Z DTSTAMP:20240328T203211Z DTSTART:20191210T140000Z LOCATION: SEQUENCE:0 SUMMARY:PSI Webinar - Main statistical approaches for quantitative decision -making in drug development UID:RFCALITEM638472547315091336 X-ALT-DESC;FMTTYPE=text/html:
Date: \;10th D
ecember 2019
\nTime: 14:00 - 15:30
\nSpeakers: \;PSI
/EFSPI SIG Quantitative Decision-Making members:
\n
\n
\n
Quantitative methods to support d ecision-making in clinical drug development already exist\, but may be unk nown or unused by pharmaceutical companies. We performed a survey among ph armaceutical companies\, targeting people with different profiles (statist icians\, non-statisticians and decision-makers) working at different stage s of the clinical development (study level\, development level or portfoli o level). This survey allowed us to analyze which quantitative methods are known\, which quantitative methods are used (or not)\, what benefit is ex pected from this kind of methods\, and what are the needs for a larger use of quantitative methods to support decision-making. It permitted to under stand the gaps and some of the issues associated to the use of such method s in drug development. The webinars are intended to share the learnings fr om the survey and to promote different quantitative methods for decision-m aking.
\nRegistration: \;To register for this f
ree webinar\, please \;click here.
\n
\nPlease email \;PSI@mci-group.com
 \;if you have any questions.